Januvia: Oral medicine for Type 2 Diabetes

Januvia is a new FDA approved oral diabetes medicine that helps control blood sugar levels people with type 2 diabetes, along with diet and exercise.

Januvia has been approved by US FDA and European commission.

Type 2 diabetes is the most common form of diabetes. It is a health condition in which the body has elevated glucose or blood sugar level. When an individual suffers from type 2 diabetes the body fails to make the required amount of insulin, insulin may not work as well as needed or there is too much glucose made by the body. Kidney disease, heart disease, blindness, neurological problems can be caused due to diabetes.

According to American Diabetes Association, nearly 21 million people in US are suffering from diabetes and about 90% to 95% of people with diabetes have type 2 diabetes.

Januvia helps patients to balance out the blood sugar levels, incretin system. Incretins pass a signal to the pancreas to increase the levels of insulin and make the liver reduce its production of glucose, and helps in the regulation of blood sugar levels.

Januvia comes under the class of drugs called the DPP-4 inhibitors which enhance the body own ability to manage blood sugar levels by increasing the active levels of the prevalent incretin hormones in the body. It blocks an enzyme called the DPP – IV which causes the breakdown of these proteins. This medication can be taken can be taken once per day.

Januvia is not for patients with type 1 diabetes or for patients with diabetic ketoacidosis.

www.januvianews.com is your online resource which contains all the related information on Januvia, new oral treatment drug for type 2 diabetes. Patients can derive all the information they require from the comfort of their home and office. This site is completely user friendly and understands the needs of an individual and what he goes through while suffering from type 2 diabetes.

Consult your health care professional before you start with any medication.